Suppr超能文献

肝脏通过受体介导和非受体依赖机制摄取铁。

Hepatic uptake of iron by receptor-mediated and receptor-independent mechanisms.

作者信息

Scheiber B, Goldenberg H

机构信息

Institut für Medizinische Chemie, University of Vienna, Austria.

出版信息

Z Gastroenterol. 1996 Jun;34 Suppl 3:95-8.

PMID:8767477
Abstract

Hepatocytes can accumulate iron from transferrin via receptor- or non-receptor-mediated endocytosis or from non-transferrin iron complexes. The latter is several times more efficient than the transferrin-mediated uptake. Both pathways have some properties in common and mutually influence each other: Whereas on the one hand the non-permeant chelator DTPA as well as a polymer-conjugated desferrioxamine inhibit uptake of iron from transferrin, transferrin (in both forms, diferric or apo) itself inhibits uptake from the Fe(3+)-DTPA complex. At neutral pH, strong stimulation by reductant is observed, as well as inhibition by the prototropic agent chloroquine. This situation is reversed at acidic pH. Weak chelators stimulate uptake of iron from Fe-DTPA in hepatocytes. We conclude that the cell can labilize the chelate complex. The further mechanism of membrane passage is dependent on the environment. All the acquired iron can be found in ferritin.

摘要

肝细胞可以通过受体介导或非受体介导的内吞作用从转铁蛋白中积累铁,也可以从非转铁蛋白铁复合物中积累铁。后者比转铁蛋白介导的摄取效率高几倍。这两种途径有一些共同的特性,并且相互影响:一方面,非渗透性螯合剂二乙三胺五乙酸(DTPA)以及聚合物共轭去铁胺抑制从转铁蛋白摄取铁,而转铁蛋白(二价铁或脱铁形式)本身抑制从Fe(3+)-DTPA复合物摄取铁。在中性pH值下,观察到还原剂有强烈刺激作用,以及质子移变剂氯喹有抑制作用。在酸性pH值下这种情况则相反。弱螯合剂刺激肝细胞从Fe-DTPA摄取铁。我们得出结论认为,细胞可以使螯合物复合物不稳定。膜通道的进一步机制取决于环境。所有获取的铁都可以在铁蛋白中找到。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验